BETA-ADRENORECEPTOR-BLOCKING AGENTS AND LIPID-METABOLISM

被引:33
作者
ENGLAND, JDF [1 ]
HUA, ASP [1 ]
SHAW, J [1 ]
机构
[1] UNIV MELBOURNE, ROYAL MELBOURNE HOSP, DEPT MED, MELBOURNE 3050, VICTORIA, AUSTRALIA
来源
CLINICAL SCIENCE AND MOLECULAR MEDICINE | 1978年 / 55卷
关键词
D O I
10.1042/cs055323s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S323 / S324
页数:2
相关论文
共 4 条
  • [1] GLUCAGON LEVELS IN NORMAL AND DIABETIC SUBJECTS - USE OF A SPECIFIC IMMUNOABSORBENT FOR GLUCAGON RADIOIMMUNOASSAY
    ALFORD, FP
    BLOOM, SR
    NABARRO, JDN
    [J]. DIABETOLOGIA, 1977, 13 (01) : 1 - 6
  • [2] ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION
    AMES, RP
    HILL, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) : 748 - 757
  • [3] EFFECT OF CHRONIC ADMINISTRATION OF PROPRANOLOL ON LIPOPROTEIN COMPOSITION
    TANAKA, N
    SAKAGUCHI, S
    OSHIGE, K
    NIIMURA, T
    KANEHISA, T
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (10): : 1071 - 1075
  • [4] METABOLIC EFFECTS OF BETA-ADRENORECEPTOR BLOCKERS
    WAALMANNING, HJ
    [J]. DRUGS, 1976, 11 : 121 - 126